ONCT - Oncternal Therapeutics, Inc.
IEX Last Trade
0.5477
-1.162 -212.215%
Share volume: 0
Last Updated: Mon 02 Dec 2024 09:06:57 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.71
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-03 | 2023-03-09 | 2023-05-04 | 2023-08-10 | 2023-11-09 | 2024-03-07 | 2024-05-09 | |
| Total revenue | 191.000 K | 382.000 K | 171.000 K | 203.000 K | 106.000 K | 179.000 K | 297.000 K | 569.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 191.000 K | 382.000 K | 171.000 K | 203.000 K | 106.000 K | 179.000 K | 297.000 K | 569.000 K | |
| 100.00% | -55.24% | 18.71% | -47.78% | 68.87% | 65.92% | 91.58% | |||
| Operating expenses | 11.986 M | 11.707 M | 12.086 M | 12.346 M | 9.651 M | 10.569 M | 9.933 M | 9.348 M | |
| Selling general and admin | 3.225 M | 3.265 M | 3.288 M | 3.315 M | 3.074 M | 3.094 M | 3.263 M | 3.289 M | |
| Research and development | 8.761 M | 8.442 M | 8.798 M | 9.031 M | 6.577 M | 7.475 M | 6.670 M | 6.059 M | |
| Total expenses | 11.986 M | 11.707 M | 12.086 M | 12.346 M | 9.651 M | 10.569 M | 9.933 M | 9.348 M | |
| -2.33% | 3.24% | 2.15% | -21.83% | 9.51% | -6.02% | -5.89% | |||
| Operating income | -11.795 M | -11.325 M | -11.915 M | -12.143 M | -9.545 M | -10.390 M | -9.636 M | -8.779 M | |
| Ebit | -11.795 M | -11.325 M | -11.915 M | -12.143 M | -9.545 M | -10.390 M | -9.636 M | -8.779 M | |
| Pretax income | -11.741 M | -11.125 M | -11.400 M | -11.487 M | -8.966 M | -9.862 M | -9.164 M | -8.388 M | |
| -5.25% | 2.47% | 0.76% | -21.95% | 9.99% | -7.08% | -8.47% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -11.741 M | -11.125 M | -11.400 M | -11.487 M | -8.966 M | -9.862 M | -9.164 M | -8.388 M | |
| 5.25% | -2.47% | -0.76% | 21.95% | -9.99% | 7.08% | 8.47% | |||
| Net income | -11.741 M | -11.125 M | -11.400 M | -11.487 M | -8.966 M | -9.862 M | -9.164 M | -8.388 M | |
| 5.25% | -2.47% | -0.76% | 21.95% | -9.99% | 7.08% | 8.47% |